Skip to main content

Jessica Korpacz

News
09/16/2021
A recent systematic review of the safety of biologics for the treatment of autoimmune/inflammatory diseases in recipients of solid-organ transplants found that no therapeutic or demographic factors were associated with the occurrence of...
A recent systematic review of the safety of biologics for the treatment of autoimmune/inflammatory diseases in recipients of solid-organ transplants found that no therapeutic or demographic factors were associated with the occurrence of...
A recent systematic review of...
09/16/2021
The Dermatologist
News
09/17/2021
Light-emitting diode therapy increased the number of hairs and their thickness after 10 irradiations and the hair remained that way when measured again 6 months later at a follow-up visit.
Light-emitting diode therapy increased the number of hairs and their thickness after 10 irradiations and the hair remained that way when measured again 6 months later at a follow-up visit.
Light-emitting diode therapy...
09/17/2021
The Dermatologist
News
09/17/2021
Researchers compared the main adverse events of treatments for advanced basal cell carcinoma, finding sonidegib is tolerated better by more patients because of the lower overall incidence rate and a slower, less severe onset of certain AEs.
Researchers compared the main adverse events of treatments for advanced basal cell carcinoma, finding sonidegib is tolerated better by more patients because of the lower overall incidence rate and a slower, less severe onset of certain AEs.
Researchers compared the main...
09/17/2021
The Dermatologist
News
09/17/2021
Analysis revealed that the efficacy of tofacitinib was greater than the placebo after 3 months of treating PsaA regardless of background doses of methotrexate.
Analysis revealed that the efficacy of tofacitinib was greater than the placebo after 3 months of treating PsaA regardless of background doses of methotrexate.
Analysis revealed that the...
09/17/2021
The Dermatologist
News
09/17/2021
A population-based study found that patients across all IMIDs were more likely to be tested for SARS-CoV-2, though this group tested positive for SARS-CoV-2 at the same rate as those without IMIDs.
A population-based study found that patients across all IMIDs were more likely to be tested for SARS-CoV-2, though this group tested positive for SARS-CoV-2 at the same rate as those without IMIDs.
A population-based study found...
09/17/2021
The Dermatologist
News
09/17/2021
The FUTURE 5 study revealed that secukinumab can improve nail disease as well as signs and symptoms of PsA and a low rate of radiographic progression for 2 years in patients who experience PsA with noncomitant nail psoriasis.
The FUTURE 5 study revealed that secukinumab can improve nail disease as well as signs and symptoms of PsA and a low rate of radiographic progression for 2 years in patients who experience PsA with noncomitant nail psoriasis.
The FUTURE 5 study revealed that...
09/17/2021
The Dermatologist
News
09/17/2021
Body surface area of patients with severe psoriasis was assessed to be a strong predictor of developing psoriatic arthritis with obesity and depression being additive risk factors.
Body surface area of patients with severe psoriasis was assessed to be a strong predictor of developing psoriatic arthritis with obesity and depression being additive risk factors.
Body surface area of patients...
09/17/2021
The Dermatologist
Feature Story
12/08/2021
Clinical trials offer advantages to both physicians and their patients, from a business investment to access to novel therapeutics for various diseases.
Clinical trials offer advantages to both physicians and their patients, from a business investment to access to novel therapeutics for various diseases.
Clinical trials offer advantages...
12/08/2021
The Dermatologist